Heterocyclic compounds with effects against neurodegenerative diseases
Novel, non-peptidic active agents based on aminopyrazoles imitate and bind abnormal b-sheet structures of peptides and proteins characteristic of Alzheimer?s diseases and TSE diseases. TSE diseases are transmissible spongiform encephalopathies.<p>
The novel active agents feature a rigid structure and a characteristic donor-acceptor-donor motive that recognizes abnormal b-sheet structures of peptides and proteins as in the lock-key-principle. For this reason, the formation and aggregation of the b-amyloid plaques, which pervade the patients? cortex and cause the dying off of neurons and a gradual loss of brain function, is inhibited.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
High-energy-density aqueous battery based on halogen multi-electron transfer
Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…
First-ever combined heart pump and pig kidney transplant
…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…
Biophysics: Testing how well biomarkers work
LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…
